is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Since its foundation in 1969, IMI has been exclusively devoted to the needs of the compounding pharmacist. As a result, they deliver the quality, service, and value that only a specialized partner can offer. Their legacy of partnerships with compounding professionals from around the world enables IMI to respond to the voice of the customer with specialized products that meet the unique needs of the compounding industry.
Their highly trained teams of customer service, engineering, and regulatory professionals are recognized internationally for their exceptional capabilities and service. The distinctive mix of specialized focus, collaboration, and capabilities makes IMI a premier partner of over 85% of the top Outsource Compounders in the U.S.
IMI offers a comprehensive suite of sterile products, ranging from tamper-evident closures for drug delivery devices to specialty needles and more. IMI takes pride in its strict quality controls and in-house, American-made manufacturing. Their state-of-the-art facilities are FDA registered and certified to meet the requirements of ISO13485.
IMI representatives will be live in the USA Partner Pavilion H1.E14, January 24th through January 27, 10:00 – 18:00, discussing new international partnerships, providing education on the benefits of IMI tamper-evident technologies, and giving live demonstrations.
IMI is currently seeking international distribution partnerships. Please contact IMI directly for available opportunities, book your appointment through Arab Health Online or visit Booth H1.E54 for more information.
For more information about IMI, visit https://IMIweb.com.